By Robert FitzPatrick : On March 12, 2014, Herbalife (NYSE: HLF ) announced it received a Civil Investigative Demand from the Federal Trade Commission, FTC. This FTC action was generally viewed as being prompted, at least in part, by the critical information published by the hedge fund, Pershing ...
put options has increased significantly. However, shares of other multi-level marketing companies, namely Usana (NYSE: USNA ) and NuSkin (NYSE: NUS ), trade at significantly higher multiples than Herbalife. Below I show the earnings multiples Complete
Graham. I found about 20 firms that make the grade; here’s a look at some of the best of the bunch. USANA Health Sciences ( USNA ) : Utah-based USANA ($440 million market cap) makes nutritional and personal care products that it sells
Steve Alexander submits: The Magic Formula Investing (MFI) strategy is a ranking system. Any particular universe of stocks can be ranked in the strategy's fashion - a composite of highest earnings yield and highest adjusted return on capital , both factors equally weighted. You can apply the ...
We are no longer providing equity research on Usana Health Sciences USNA . We provide broad coverage of more than 1,800 companies across 91 industry groups and adjust our coverage as necessary based on client demand and investor interest.
Usana Health Sciences ' USNA first-quarter results came in about where we expected, and we don't expect to alter our fair value estimate. Sales fell 4
On Monday, Usana Health Sciences USNA announced fourth-quarter and full-year earnings that were essentially in line with management's lowered guidance. Fourth
On Thursday, Usana Health Sciences USNA preannounced fourth-quarter and full-year 2008 earnings. Although the firm underperformed relative to management's forecast
We've lowered our fair value uncertainty rating for Usana Health Sciences USNA to very high from extreme. While we still have some deep reservations about the management of this firm (above and beyond the
Usana Health Sciences USNA reported weak third-quarter results. However, we are holding tight on our fair value estimate, as the firm's results through